REDWOOD CITY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric ...
REDWOOD CITY, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux® ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences announced today that the Karp Laboratory at the Brigham and Women’s Hospital (BWH) has purchased the BioFlux 1000 system, which will ...
REDWOOD CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric ...
REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k) ...
Atrial fibrillation, or Afib, is a condition where the heart races or quivers, resulting in an irregular heartbeat. As many as six million Americans have it and the CDC suggests that number will ...
The BioFlux 200+ and BioFlux 1000HT are game changers for researchers who require robust and reliable instruments that offer higher throughput than current DIY Shear Flow setups.” — Scott McGinnis, VP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results